IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Horizon Pharma Financing

CUSIP: 44052RAA3 | 1 institutional holders

Quarters

Q1 2016Q4 2015
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2016

Advent Capital Management3,750,000
0.0% of portfolio›$3.3K
StyleTurnoverLocationFiled
Advent Capital Management
3,750,000$3.3K0.0%Deep ValueMediumNew York, NY2016-05-13